Megan Auzenbergs

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (19)

• Rebalancing power in infectious disease modelling: Toward inclusive and contextual approaches
  PLOS Global Public Health 2026 DOI: 10.1371/journal.pgph.0006220
  +Save
• Vaccination strategies against wild poliomyelitis in polio-free settings: outbreak risk modelling study and cost-effectiveness analysis
  Megan Auzenbergs, Kaja Abbas, Arie Voorman +3 more
  BMJ Global Health 2025 DOI: 10.1136/bmjgh-2024-016013
  +Save
• Sub-national modelling of surveillance sensitivity to inform declaration of disease elimination
  2025 DOI: 10.1101/2025.01.30.25321401
  +Save
• Programmatic considerations and evidence gaps for chikungunya vaccine introduction in countries at risk of chikungunya outbreaks: Stakeholder analysis
  Megan Auzenbergs, Clara Maure, Hyolim Kang +4 more
  PLOS Neglected Tropical Diseases 2024 DOI: 10.1371/journal.pntd.0012075
  +Save
• Chikungunya seroprevalence, force of infection, and prevalence of chronic disability after infection in endemic and epidemic settings: a systematic review, meta-analysis, and modelling study
  Hyolim Kang, Megan Auzenbergs, Hannah Clapham +10 more
  The Lancet Infectious Diseases 2024 DOI: 10.1016/S1473-3099(23)00810-1
  +Save
• Programmatic considerations for chikungunya vaccine introduction in countries at risk of chikungunya outbreaks: stakeholder analysis
  2023 DOI: 10.1101/2023.09.26.23296129
  +Save
• Outbreak risks, cases, and costs of vaccination strategies against wild poliomyelitis in polio-free settings: a modelling study
  2023 DOI: 10.1101/2023.07.05.23292288
  +Save
• The impact of surveillance and other factors on detection of emergent and circulating vaccine derived polioviruses [version 3; peer review: 2 approved, 1 approved with reservations]
  2023 DOI: 10.12688/gatesopenres.13272.3
  +Save
• Chikungunya Seroprevalence, Force of Infection, and Prevalence of Chronic Disability in Endemic and Epidemic Settings: Systematic Review, Meta-Analysis, and Modelling Study
  SSRN 2023 DOI: 10.2139/ssrn.4617040
  +Save
• Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study
  Megan Auzenbergs, Han Jing Fu, Kaja Abbas +3 more
  The Lancet Global Health 2023 DOI: 10.1016/S2214-109X(23)00220-6
  +Save
• The impact of surveillance and other factors on detection of emergent and circulating vaccine derived polioviruses
  Gates Open Research 2022 DOI: 10.12688/gatesopenres.13272.2
  +Save
• Health Impact of Routine Measles Vaccination and Supplementary Immunisation Activities in 14 High Burden Countries: A DynaMICE Modelling Study
  2022 DOI: 10.2139/ssrn.4159564
  +Save
• Health impact of routine measles vaccination and supplementary immunisation activities in 14 high burden countries: A DynaMICE modelling study
  medRxiv 2022 DOI: 10.1101/2022.07.11.22277494
  +Save
• The impact of surveillance and other factors on detection of emergent and circulating vaccine derived polioviruses
  Gates Open Research 2021 DOI: 10.12688/gatesopenres.13272.1
  +Save
• The importance of supplementary immunisation activities to prevent measles outbreaks during the COVID-19 pandemic in Kenya
  CN Mburu, John Ojal, R Chebet +16 more
  BMC Medicine 2021 DOI: 10.1186/s12916-021-01906-9
  +Save
• The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation
  The Lancet Infectious Diseases 2021 DOI: 10.1016/S1473-3099(21)00079-7
  +Save
• Effective transmission across the globe: the role of climate in COVID-19 mitigation strategies
  The Lancet Planetary Health 2020 DOI: 10.1016/s2542-5196(20)30106-6
  +Save
• Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection
  Kaja Abbas, Simon R. Procter, Kevin van Zandvoort +43 more
  The Lancet Global Health 2020 DOI: 10.1016/S2214-109X(20)30308-9
  +Save
• Desirable BUGS in models of infectious diseases
  Epidemics 2019 DOI: 10.1016/j.epidem.2019.100361
  +Save